輸入代號或公司名稱後按 Enter
4127

天良

+0.80 (+1.36%)最後更新 2026-09-16
台灣 · 上櫃 · 生技醫療業
59.80126成交張數39.07本益比5.20股價淨值比0.00%殖利率2026-09-16資料日期

綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入

營業收入2025512年增 +32.9%
毛利率202556.3%最新一期
營業利益率2025-3.2%最新一期
每股盈餘2025-0.22年增 -184.6%
會計項目走勢2016201720182019202020212022202320242025
銷貨收入100.0%
銷貨收入淨額100.0%100.0%
營業收入合計100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%100.0%
銷貨成本40.3%43.7%
營業成本合計40.3%50.3%47.3%40.6%41.6%40.8%36.3%37.8%40.3%43.7%
營業毛利(毛損)59.7%49.7%52.7%59.4%58.4%59.2%63.7%62.2%59.7%56.3%
營業毛利(毛損)淨額59.7%49.7%52.7%59.4%58.4%59.2%63.7%62.2%59.7%56.3%
推銷費用50.8%68.7%53.2%58.1%58.4%43.5%43.7%47.9%46.0%48.1%
管理費用12.9%18.7%11.2%11.0%11.5%8.0%8.7%9.9%12.9%10.5%
研究發展費用0.2%0.3%0.5%0.2%0.3%0.2%0.3%0.3%0.6%0.9%
營業費用合計64.0%87.8%64.9%69.3%70.2%51.7%52.6%57.8%59.5%59.4%
營業利益(損失)-4.3%-37.9%-12.2%-10.0%-11.8%7.5%11.0%4.4%0.2%-3.2%
利息收入0.0%0.0%0.0%0.1%1.2%5.0%
其他收入0.2%1.2%1.0%1.1%1.2%1.4%0.6%0.1%0.6%0.2%
其他利益及損失淨額-1.9%-0.3%-6.1%-0.1%-0.3%-0.0%-0.1%-0.2%2.2%-2.2%
財務成本淨額1.2%1.3%0.6%0.6%0.5%0.3%0.3%0.5%0.8%2.2%
營業外收入及支出合計-2.9%-0.4%-5.8%0.4%0.5%1.0%0.2%-0.4%3.2%0.9%
稅前淨利(淨損)-7.1%-38.3%-18.0%-9.6%-11.3%8.5%11.2%4.0%3.4%-2.3%
所得稅費用(利益)合計-0.1%1.2%-0.2%1.2%0.7%0.4%-0.0%0.1%0.4%-0.3%
繼續營業單位本期淨利(淨損)-7.1%-39.5%-17.8%-10.7%-12.0%8.2%11.3%3.9%3.0%-2.0%
本期淨利(淨損)-7.1%-39.5%-17.8%-10.7%-12.0%8.2%11.3%3.9%3.0%-2.0%
確定福利計畫之再衡量數0.1%-1.3%0.0%-0.0%-0.1%0.0%0.4%0.0%2.8%0.1%
與不重分類之項目相關之所得稅0.0%-0.2%0.0%-0.0%-0.0%0.0%0.1%0.0%0.6%0.0%
不重分類至損益之項目:-0.0%-0.1%0.0%0.3%0.0%2.3%0.1%
透過其他綜合損益按公允價值衡量之債務工具投資未實現評價損益-3.3%1.1%
後續可能重分類至損益之項目:-3.3%1.1%
其他綜合損益(淨額)0.1%-1.1%0.0%-0.0%-0.1%0.0%0.3%0.0%-1.0%1.2%
本期綜合損益總額-7.0%-40.5%-17.8%-10.7%-12.1%8.2%11.6%3.9%2.0%-0.8%
母公司業主(淨利∕損)-7.1%-39.5%-17.7%-10.7%-2.0%
母公司業主(綜合損益)-7.0%-40.5%-17.7%-10.7%-0.8%
基本每股盈餘-0.2%-0.9%-0.4%-0.2%-0.3%0.2%0.2%0.1%0.1%-0.0%
稀釋每股盈餘-0.2%0.2%0.1%0.1%-0.0%
預期信用減損損失(利益)-0.1%0.0%0.0%-0.3%0.0%
非控制權益(淨利∕損)-0.1%0.0%
非控制權益(綜合損益)-0.1%0.0%
其他收益及費損淨額0.0%0.2%0.0%

金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。